We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTHX
1526
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$381K ﹤0.01%
15,694
NWS icon
1527
News Corp Class B
NWS
$17.8B
$381K ﹤0.01%
31,848
+460
+1% +$4.98K
GWB
1528
DELISTED
Great Western Bancorp, Inc.
GWB
$380K ﹤0.01%
27,651
+4,141
+18% +$65.7K
UCTT
1529
Ultra Clean Holdings
UCTT
$4.27B
$380K ﹤0.01%
16,793
KDMN
1530
DELISTED
Kadmon Holdings, Inc.
KDMN
$378K ﹤0.01%
73,735
+8,601
+13% +$38.6K
VRTS icon
1531
Virtus Investment Partners
VRTS
$1.14B
$377K ﹤0.01%
3,239
LADR
1532
Ladder Capital
LADR
$1.27B
$376K ﹤0.01%
46,377
RTL
1533
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$376K ﹤0.01%
47,324
FIZZ icon
1534
National Beverage
FIZZ
$2.93B
$375K ﹤0.01%
12,288
+2,724
+28% +$73.5K
CSR
1535
Centerspace
CSR
$934M
$375K ﹤0.01%
5,316
+656
+14% +$41.9K
FRO icon
1536
Frontline
FRO
$9.02B
$373K ﹤0.01%
+53,437
New +$454K
CNST
1537
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$372K ﹤0.01%
12,376
+3,776
+44% +$136K
CCS icon
1538
Century Communities
CCS
$2.02B
$371K ﹤0.01%
12,109
DOMO icon
1539
Domo
DOMO
$188M
$370K ﹤0.01%
11,491
+4,048
+54% +$90.1K
MLAB icon
1540
Mesa Laboratories
MLAB
$635M
$370K ﹤0.01%
1,705
BRKL
1541
DELISTED
Brookline Bancorp
BRKL
$369K ﹤0.01%
36,642
CBB
1542
DELISTED
Cincinnati Bell Inc.
CBB
$369K ﹤0.01%
24,831
+5,314
+27% +$78.4K
PSN icon
1543
Parsons
PSN
$5.08B
$368K ﹤0.01%
10,160
+1,648
+19% +$61.9K
DVAX
1544
DELISTED
Dynavax Technologies
DVAX
$368K ﹤0.01%
41,452
EVER icon
1545
EverQuote
EVER
$877M
$367K ﹤0.01%
6,305
+2,259
+56% +$106K
EGIO
1546
DELISTED
Edgio, Inc. Common Stock
EGIO
$366K ﹤0.01%
1,244
FCF icon
1547
First Commonwealth Financial
FCF
$2.18B
$365K ﹤0.01%
44,099
+4,759
+12% +$40.1K
HCC icon
1548
Warrior Met Coal
HCC
$5.02B
$365K ﹤0.01%
23,723
PRKS icon
1549
United Parks & Resorts
PRKS
$2.05B
$365K ﹤0.01%
24,632
+5,300
+27% +$78.1K
BHE icon
1550
Benchmark Electronics
BHE
$2.9B
$365K ﹤0.01%
16,877

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.